BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21729761)

  • 1. Statins and outcome after hospitalization for COPD exacerbation: a prospective study.
    Bartziokas K; Papaioannou AI; Minas M; Kostikas K; Banya W; Daniil ZD; Haniotou A; Gourgoulianis KI
    Pulm Pharmacol Ther; 2011 Oct; 24(5):625-31. PubMed ID: 21729761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin use and risk of COPD exacerbation requiring hospitalization.
    Wang MT; Lo YW; Tsai CL; Chang LC; Malone DC; Chu CL; Liou JT
    Am J Med; 2013 Jul; 126(7):598-606.e2. PubMed ID: 23684060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.
    Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ;
    PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
    Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
    Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetuin-A is associated with disease severity and exacerbation frequency in patients with COPD.
    Minas M; Mystridou P; Georgoulias P; Pournaras S; Kostikas K; Gourgoulianis KI
    COPD; 2013 Feb; 10(1):28-34. PubMed ID: 23272665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hospitalisations for exacerbations of COPD on health-related quality of life.
    Esteban C; Quintana JM; Moraza J; Aburto M; Egurrola M; España PP; Pérez-Izquierdo J; Aguirre U; Aizpiri S; Capelastegui A
    Respir Med; 2009 Aug; 103(8):1201-8. PubMed ID: 19272762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin use and hospitalization in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study in Taiwan.
    Huang CC; Chan WL; Chen YC; Chen TJ; Chou KT; Lin SJ; Chen JW; Leu HB
    Clin Ther; 2011 Oct; 33(10):1365-70. PubMed ID: 21962452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study.
    Blamoun AI; Batty GN; DeBari VA; Rashid AO; Sheikh M; Khan MA
    Int J Clin Pract; 2008 Sep; 62(9):1373-8. PubMed ID: 18422598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of changes in physical activity on frequency of hospitalization in chronic obstructive pulmonary disease.
    Esteban C; Arostegui I; Aburto M; Moraza J; Quintana JM; Aizpiri S; Basualdo LV; Capelastegui A
    Respirology; 2014 Apr; 19(3):330-8. PubMed ID: 24483954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease.
    Calverley PM; Sanchez-Toril F; McIvor A; Teichmann P; Bredenbroeker D; Fabbri LM
    Am J Respir Crit Care Med; 2007 Jul; 176(2):154-61. PubMed ID: 17463412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease.
    Almagro P; Barreiro B; Ochoa de Echaguen A; Quintana S; Rodríguez Carballeira M; Heredia JL; Garau J
    Respiration; 2006; 73(3):311-7. PubMed ID: 16155352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations.
    Lin CM; Yang TM; Yang YH; Tsai YH; Lee CP; Chen PC; Chen WC; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2020; 15():289-299. PubMed ID: 32103928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year change in health status and subsequent outcomes in COPD.
    Wilke S; Jones PW; Müllerova H; Vestbo J; Tal-Singer R; Franssen FM; Agusti A; Bakke P; Calverley PM; Coxson HO; Crim C; Edwards LD; Lomas DA; MacNee W; Rennard SI; Yates JC; Wouters EF; Spruit MA
    Thorax; 2015 May; 70(5):420-5. PubMed ID: 25782757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with changes in quality of life of COPD patients: a prospective study in primary care.
    Monteagudo M; Rodríguez-Blanco T; Llagostera M; Valero C; Bayona X; Ferrer M; Miravitlles M
    Respir Med; 2013 Oct; 107(10):1589-97. PubMed ID: 23786889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.
    Fan VS; Ramsey SD; Make BJ; Martinez FJ
    COPD; 2007 Mar; 4(1):29-39. PubMed ID: 17364675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression, but not sleep disorder, is an independent factor affecting exacerbations and hospitalization in patients with chronic obstructive pulmonary disease.
    Ito K; Kawayama T; Shoji Y; Fukushima N; Matsunaga K; Edakuni N; Uchimura N; Hoshino T
    Respirology; 2012 Aug; 17(6):940-9. PubMed ID: 22564039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use and exacerbations in individuals with chronic obstructive pulmonary disease.
    Ingebrigtsen TS; Marott JL; Nordestgaard BG; Lange P; Hallas J; Vestbo J
    Thorax; 2015 Jan; 70(1):33-40. PubMed ID: 25349333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease.
    Almagro P; Salvadó M; Garcia-Vidal C; Rodríguez-Carballeira M; Cuchi E; Torres J; Heredia JL
    Respiration; 2012; 84(1):36-43. PubMed ID: 21996555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender associated differences in determinants of quality of life in patients with COPD: a case series study.
    de Torres JP; Casanova C; Hernández C; Abreu J; Montejo de Garcini A; Aguirre-Jaime A; Celli BR
    Health Qual Life Outcomes; 2006 Sep; 4():72. PubMed ID: 17007639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.